Transcriptional Alterations Related to Neuropathology and Clinical Manifestation of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most common cause of dementia in the human population, characterized by a spectrum of neuropathological abnormalities that results in memory impairment and loss of other cognitive processes as well as the presence of non-cognitive symptoms. Transcriptomic analyses provide an important approach to elucidating the pathogenesis of complex diseases like AD, helping to figure out both pre-clinical markers to identify susceptible patients and the early pathogenic mechanisms to serve as therapeutic targets. This study provides the gene expression profile of postmortem brain tissue from subjects with clinic-pathological AD (Braak IV, V, or V and CERAD B or C; and CDR ≥1), preclinical AD (Braak IV, V, or VI and CERAD B or C; and CDR = 0), and healthy older individuals (Braak ≤ II and CERAD 0 or A; and CDR = 0) in order to establish genes related to both AD neuropathology and clinical emergence of dementia. Based on differential gene expression, hierarchical clustering and network analysis, genes involved in energy metabolism, oxidative stress, DNA damage/repair, senescence, and transcriptional regulation were implicated with the neuropathology of AD; a transcriptional profile related to clinical manifestation of AD could not be detected with reliability using differential gene expression analysis, although genes involved in synaptic plasticity, and cell cycle seems to have a role revealed by gene classifier. In conclusion, the present data suggest gene expression profile changes secondary to the development of AD-related pathology and some genes that appear to be related to the clinical manifestation of dementia in subjects with significant AD pathology, making necessary further investigations to better understand these transcriptional findings on the pathogenesis and clinical emergence of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Genes involved in oxidative stress and in DNA damage/repair were found to be coupled with AD neuropathology.”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [24]
In the citing paper
“through gene classifiers, we revealed that genes related to the cell-cycle were able to discriminate between CP-AD and P-AD subjects, indicating a possible role for those biological processes in brain resilience.”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“Neurofibrillary tangles (NFTs) and neuritic plaques (NPs) were assessed by a skilled neuropathologist in accordance with the Braak and Braak stage system [37], and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [5], respectively.”
BackgroundMethodThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 7×
“Gene Expression Profile Related to AD Pathology To address which genes were related to the neuropathological processes of AD (‘‘neuropathological AD-related genes’’, npADGs), we compared the gene expression profile (Student’s ttest, P#0.01) of subjects who have been histopathologically confirmed to demonstrate patholo…”
BackgroundMethodInfluentialTM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837 · cited 1×
“01 with 1000 permutations by MEV (MultiExperiment Viewer – Boston, MA, USA) software [42].”
MethodHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Research works printed but not linked: 1
- Williams C, Mehrian Shai R, Wu Y, Hsu YH, Sitzer T, et al (2009) Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer’s disease. PLoS One 4: e4936. 19295912 PMC2654156 · DOI · Paper page
Cited by
Xu, M., Zhang, D., Luo, R., Wu, Y., Zhou, H., Kong, L., Bi, R., & Yao, Y. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.08.012 · Cited by 296
“EC GSE26927 [19, 20] 11 4 15 GPL6255 17189 7.”
BackgroundInfluentialAge and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole
Pereira, A. C., Gray, J. D., Kogan, J. F., Davidson, R. L., Rubin, T. G., Okamoto, M., Morrison, J. H., & McEwen, B. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.33 · Cited by 116
Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
“To uncover the molecular aspects that underlie these pathophysiological processes and resilient brain aging, we performed a gene expression study among subjects with 1) clinical dementia and AD pathology (CPAD), 2) AD pathology and healthy cognition (P-AD), and normal individuals (N) [24].”
MethodSelf-citationZheng, M., Ye, H., Yang, X., Shen, L., Dang, X., Liu, X., Gong, Y., Wu, Q., Wang, L., Ge, X., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.016 · Cited by 106
Mendes‐Silva, A. P., Pereira, K. S., Araújo, G. T. T., Nicolau, E. D. S., Silva-Ferreira, C. M., Teixeira, A. L., & Diniz, B. S. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.07.017 · Cited by 80
Self-citationInnate immune response is differentially dysregulated between bipolar disease and schizophrenia
de Baumont, A., Maschietto, M. C., Lima, L., Carraro, D. M., Olivieri, E. H. R., Fiorini, A., Barreta, L. A. N., Palha, J. A., Belmonte-de-Abreu, P. S., Moreira‐Filho, C. A., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.055 · Cited by 83
“To assess differences in network organization between individuals with BD and SZ, co-expression of pairs of genes were evaluated as previously described (Silva et al., 2012).”
MethodSelf-citationWilliams, G., Gatt, A., Clarke, E., Corcoran, J., Doherty, P., Chambers, D., & Ballard, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0555-x · Cited by 69
Gene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease
Saura, C. A., Parra-Damas, A., & Enriquez-Barreto, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00318 · Cited by 65
“…and transcriptional regulation processes exacerbate in the brain during the progression of AD pathology contributing likely to cognitive dysfunction (Yao et al., 2003; Blalock et al., 2004; Liang et al., 2008; Miller et al., 2008; Tan et al., 2010; Silva et al., 2012; Berchtold et al., 2013).”
BackgroundHassan, M., Raza, H., Abbasi, M. A., Moustafa, A. A., & Seo, S.-Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.115 · Cited by 61
Naughton, B. J., Duncan, F. J., Murrey, D. A., Meadows, A. S., Newsom, D. E., Stoicea, N., White, P., Scharre, D. W., Mccarty, D. M., & Fu, H. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140606 · Cited by 59
“The AD transcriptional profile studies by microarray have mostly tested postmortem brain tissues [28, 29].”
Villela, D., Ramalho, R. F., Silva, A. R. T., Brentani, H., Suemoto, C. K., Pasqualucci, C. A., Grinberg, L. T., Krepischi, A. C. V., & Rosenberg, C. (2016) · Neural Plasticity · doi:10.1155/2016/2584940 · Cited by 52
“Total RNA was isolated using the RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. cDNA amplification, labeling, and hybridization were performed as previously described [20].”
Self-citationZolochevska, O., & Taglialatela, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518142110 · Cited by 49
“describe six genes which allowed them to distinguish these two groups, suggesting that differential expression of specific genes could represent a possible compensatory mechanism in NDAN to resist dementia [10].”
BackgroundSimpson, J. E., Ince, P. G., Minett, T., Matthews, F. E., Heath, P. R., Shaw, P. J., Goodall, E., Garwood, C. J., Ratcliffe, L. E., Brayne, C., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12252 · Cited by 46
Cell type-specific potential pathogenic genes and functional pathways in Alzheimer’s Disease
Wang, X.-L., & Li, L. (2021) · BMC Neurology · doi:10.1186/s12883-021-02407-1 · Cited by 46
Kikuchi, M., Sekiya, M., Hara, N., Miyashita, A., Kuwano, R., Ikeuchi, T., Iijima, K., & Nakaya, A. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddz320 · Cited by 48
Lachén‐Montes, M., Zelaya, M. V., Segura, V., Fernández‐Irigoyen, J., & Santamaría, E. (2017) · Oncotarget · doi:10.18632/oncotarget.18193 · Cited by 31
“As in other transcriptomic studies performed in AD brains [15, 78], we did not achieve significant results using this criteria, so we worked with a p-value < 0.”
Gene Expression Profile and Functional Analysis of Alzheimer’s Disease
Chen, F., Guan, Q., Nie, Z.-Y., & Jin, L.-J. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513500838 · Cited by 22
“Silva et al studied the gene expression profile of postmortem brain tissue from patients with AD and found that genes involved in energy metabolism, oxidative stress, DNA damage/repair, senescence, and transcriptional regulation were implicated with the neuropathology of AD.(8) Focusing on genes associated with energy…”
BackgroundTranscriptomics of cortical gray matter thickness decline during normal aging
Kochunov, P., Charlesworth, J., Winkler, A. M., Hong, L. E., Nichols, T. E., Curran, J. E., Sprooten, E., Jahanshad, N., Thompson, P. M., Johnson, M. P., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.066 · Cited by 23
“The same functional categories were also implicated in development of Alzheimer's disease (Silva et al., 2011).”
BackgroundSree, G. N. S. H., Rajalekshmi, S. G., & Burri, R. R. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01919-2 · Cited by 21
Devanarayan, P., Devanarayan, V., Llano, D. A., & (ADNI), T. A. D. N. I. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180905 · Cited by 20
Luckett, E. S., Zielonka, M., Kordjani, A., Schaeverbeke, J. M., Adamczuk, K., Meyer, S. D., Laere, K. V., Dupont, P. J., Cleynen, I., & Vandenberghe, R. R. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01242-5 · Cited by 18
Alonso, M. P., Lachén‐Montes, M., González-Morales, A., Ausín, K., Pérez‐Mediavilla, A., Fernández‐Irigoyen, J., & Santamaría, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112260 · Cited by 16
“As in other transcriptomic studies performed in AD brains [56,57], we worked with a p-value < 0.”
MethodLachén‐Montes, M., González-Morales, A., Alonso, M. P., Ausín, K., Gómez-Ochoa, M., Zelaya, M. V., Ferrer, I., Pérez‐Mediavilla, A., Fernández‐Irigoyen, J., & Santamaría, E. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00141 · Cited by 16
“Different alterations of p38 MAPK pathway have been observed in the OB, hippocampus, and cortical areas at early stages in human AD (Hensley et al., 1999; Sun et al., 2003; Munoz and Ammit, 2010; Criscuolo et al., 2015).”
BackgroundRocha, N. K. R., Themoteo, R. M., Brentani, H., Forlenza, O. V., & de Paula, V. D. J. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579984 · Cited by 14
Self-citationAlzheimer’s disease prediction using three machine learning methods
Ahmed, S. T., & Kadhem, S. M. (2022) · Indonesian Journal of Electrical Engineering and Computer Science · doi:10.11591/ijeecs.v27.i3.pp1689-1697 · Cited by 14
“The information gain, chisquared test, and mean decrease gini test are among the statistical tests utilized in this study to find such gene expressions [21], [22].”
Killick, R., Elliott, C., Ribé, E. M., Broadstock, M., Ballard, C. G., Aarsland, D., & Williams, G. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311219 · Cited by 14
“In particular, the expression series and samples are as follows: NCBI GEO accession: GSE84422 (frontal pole 24 v 15 and para hippocampal gyrus 23 v 15) [49], GSE37263 (neocortex 8 v 8) [50], GSE36980 (hippocampus 7 v 10, frontal cortex 15 v 18, and temporal cortex 10 v 19) [36], GSE39420 (posterior cingulate 7 v 7) [5…”
MethodRare Variants and Transcriptomics in Alzheimer disease
Humphries, C., & Kohli, M. A. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0035-9 · Cited by 13
Bastos, E. P., Brentani, H., Pasini, F. S., Silva, A. R. T., Torres, C., Puga, R., Olivieri, E. H. R., Piovezani, A. R., Pereira, C. A. D. B., Machado‐Lima, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101656 · Cited by 12
“Co-expression analyses We performed a co-expression analysis based on a method analogous to that previously described [35].”
MethodSelf-citationGlobal expression profiling of cognitive level and decline in middle-aged monozygotic twins
Nygaard, M., Larsen, M. J., Thomassen, M., McGue, M. K., Christensen, K., Tan, Q., & Christiansen, L. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.019 · Cited by 15
Hu, L., Tang, Q., Meng, F., Xu, Y., Chen, W., & Xu, S. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168874 · Cited by 7
Abdullah, M., Wah, Y. B., Zakaria, Y., & Majeed, A. B. A. (2016) · Communications in computer and information science · doi:10.1007/978-981-10-2777-2_9 · Cited by 6
Transcriptional Profiling of Hippocampus Identifies Network Alterations in Alzheimer’s Disease
Quarato, V., D’Antona, S., Battista, P., Zupo, R., Sardone, R., Castiglioni, I., Porro, D., Frasca, M., & Cava, C. (2022) · Applied Sciences · doi:10.3390/app12105035 · Cited by 3
Therapeutic Targeting of Histone Deacetylation to Prevent Alzheimer's Disease.
Chacko, S., & Ladiges, W. (2021) · PubMed · Cited by 3
Predicting Alzheimer's Disease Using Filter Feature Selection Method
Ahmed, S. T., & Kadhem, S. M. (2022) · Iraqi Journal of Computer Communication Control and System Engineering · doi:10.33103/uot.ijccce.22.4.2 · Cited by 2
“Methods for selecting features can be based on statistics [50] , information theory [51] , manifold [52] , and rough set [53] , and can be classified according to various criteria, according to the theoretical concept.”
BackgroundSilva, A. R. T. D. (2013)
Self-citationIdentifying stage-specific markers of Alzheimer's disease using quantitative proteomics
Yagensky, O. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7052
Parallel Computing-Based Genome-Wide Epistasis Analysis of CSF Total Tau in ADNI Cohort
Zhang, Q., Liu, J., Chen, Y., Ao, L., & Chen, D. (2024) · IEEE International Conference on Medical Artificial Intelligence (MedAI) · doi:10.1109/medai62885.2024.00032
“CAPRIN1 encodes a phosphoprotein, and is expressed in post-synaptic granules in neuronal dendrites [34].”
Gaining insights into Alzheimer’s disease by predicting chromatin spatial organization
Villamán, C., Cartas‐Espinel, I., Sáez, M., & Martín, A. J. M. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf268
Innate immune response is differentially dysregulated between bipolar disease and schizophrenia
Baumont, A. D., Maschietto, M. C., Lima, L., Carraro, D. M., Olivieri, E. H., Fiorini, A., Barreta, L. A. N., Palha, J. A., Belmonte-de-Abreu, P., Filho, C. A. M., et al. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Self-citation
Metadata
- Authors
- Silva, A. R. T., Grinberg, L. T., Farfel, J. M., Diniz, B. S., Lima, L. A., Silva, P. J. S., Ferretti, R. E. L., Rocha, R. M., Filho, W. J., Carraro, D. M., & Brentani, H.
- Affiliations
- Universidade de São Paulo (BR)
- AC Camargo Hospital (BR)
- Corresponding author
- Silva, Aderbal R. T.
- Grinberg, Lea T.
- Diniz, Breno S.
- Lima, Leandro A.
- Silva, Paulo J. S.
- Rocha, Rafael M.
- Filho, Wilson Jacob
- Carraro, Dirce M.
- Brentani, Helena
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-11-07
- Volume
- 7
- Issue
- 11
- Pages
- e48751
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3492444
- OpenAlex
- W2094058326
- Cited by
- 40
- References
- 86
- Citations by year
- 2024: 3 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 5 · 2013: 3
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, gene expression profiling, postmortem brain, differential gene expression, preclinical Alzheimer's disease, energy metabolism, oxidative stress, DNA damage and repair, cellular senescence, transcriptional regulation, synaptic plasticity, cell cycle, gene classifier, Alzheimer's disease pathogenesis
- MeSH terms
- Alzheimer Disease, Brain, Dementia, DNA Damage, DNA Repair, Energy Metabolism, Gene Expression Regulation, Cluster Analysis, Cellular Senescence, Oxidative Stress, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Gene Regulatory Networks, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.